Editorial board

Editor-in-Chief:

Michelle S. Itano, University of North Carolina at Chapel Hill (NC, USA)

Editorial Board:

Richard J. Ablin, University of Arizona (AZ, USA)
Elinne Becket, California State University San Marcos (CA, USA)
Bill L. Brizzard, Brizzard Consulting LLC. (IN, USA)
Bruce Budowle, University of North Texas Health Science Center (TX, USA)
Piotr Chomczynski, Molecular Research Center (OH, USA)
Beth Cimini, Broad Institute of MIT and Harvard (MA, USA)
Rita Colwell, University of Maryland (MD, USA)
Jeffrey Felton,Western University of Health Sciences (CA, USA)
Andrew P French, University of Nottingham (UK)
Michel Goedert, MRC Laboratory of Molecular Biology (Cambridge, UK)
Peter Greshoff, University of Queensland St Lucia (Brisbane, Australia)
Yoshihide Hayashizaki, RIKEN Preventive Medicine and Diagnosis Innovation Program (Japan)
Jörg Hoheisel, Deutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany)
Leroy Hood, Institute for Systems Biology (WA, USA)
Shenglin Huang, Fudan University (China)
DeLaine Larson, University of California, San Fransisco (CA, USA)
Peter Oefner, University of Regensburg (Germany)
Steve Paddock, Howard Hughes Medical Institute (WI, USA)
Scott D. Patterson, Gilead Sciences (CA, USA)
Leonard F. Peruski, Centers for Disease Control and Prevention (GA) & Indiana University School of Medicine, Northwest Center (both USA)
George Poste, Arizona State University (AZ, USA)
Kwok Pui-Yan, Institute of Biomedical Sciences Academia Sinica (Taiwan)
John Quackenbush, Harvard School of Public Health (MA, USA)
Joshua Rappoport, Executive Director of Research Infrastructure, Boston College (MA, USA)
Barton Slatko, New England Biolabs (MA, USA)
Mathias Uhlen, Royal Institute of Technology (Stockholm, Sweeden)
Timothy Veenstra, Maranatha Baptist University (WI, USA)
Kent Vrana, Penn State College of Medicine (PA, USA)
Jennifer Waters, University of North Carolina at Chapel Hill (NC, USA)
Micheal Weiner, AxioMx (CT, USA)